alexa

GET THE APP

Recent Advances in the Chemotherapy of Breast Cancer | OMICS International| Abstract
ISSN 2472-0429

Advances in Cancer Prevention
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Review Article   
  • Adv Cancer Prev 2018, Vol 3(1): 126
  • DOI: 10.4172/2472-0429.1000126

Recent Advances in the Chemotherapy of Breast Cancer

Navya V1*, Pavan S2 and Swami AP1
1Department of Pharmacy Practice, Vishwa Bharathi College of Pharmaceutical sciences, , Perecherla, Guntur, Andhra Pradesh, India
2Department of Pharmacy Practice, Raghavendra institute of Pharmaceutical sciences, , Ananthapur, Andhra Pradesh, India
*Corresponding Author : Navya V, Department of Pharmacy Practice, Vishwa Bharathi College of Pharmaceutical sciences, Perecherla, Guntur, Andhra Pradesh, India, Tel: 8008803645, Email: [email protected]

Received Date: Jan 30, 2018 / Accepted Date: Mar 25, 2018 / Published Date: Mar 31, 2018

Abstract

In the course of recent decades, the fundamental treatment of bosom tumor (early and progressed) has changed significantly. Chemoprevention is a recently introduced and quickly developing region of oncology that is distinguishing agents with a potentially preventive part in malignancy. For as far back as 40– 50 years, and since the disclosure and further restorative utilization of Tamoxifen, a particular estrogen receptor modulator, bosom disease treatment has turned to the advancement and accomplishment of custom fitted restorative treatment. Much still should be done in enhancing results, and particularly for the individuals who have propelled breast cancer, a testing zone for medicinal oncologists. Continuous global clinical trials are right now assessing new helpful methodologies and distinguishing particular natural subsets that could decide a patient's capacity to react to specific chemotherapeutic drugs.

Keywords: Breast cancer; Chemotherapeutic drugs; Breast cancer therapeutics; Endocrine-dependent breast cancer; HER2-positive Breast cancer; Metastatic breast cancer

Citation: Navya V, Pavan S, Swami AP (2018) Recent Advances in the Chemotherapy of Breast Cancer . Adv Cancer Prev 3: 126. Doi: 10.4172/2472-0429.1000126

Copyright: © 2018 Navya V, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Recommended Conferences

40th World Cancer Conference

Rome, Italy
Article Usage
  • Total views: 3803
  • [From(publication date): 0-2018 - Aug 05, 2021]
  • Breakdown by view type
  • HTML page views: 3569
  • PDF downloads: 234
Top